Phase 3 factorial RCT in 437 adults with HIV-related sepsis (395 analysed): neither immediate nor high-dose antituberculosis therapy reduced 28-day mortality (25% vs 25%, aHR 0.99; 26% vs 25%, aHR 1.07). Liver injury was numerically higher with immediate high dose.
RCTn = 437
Heysell et al. Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial